Breakthrough Treatments in Multiple Sclerosis
This CME/CE course provides a comprehensive exploration of cutting-edge advancements in diagnosing and treating Multiple Sclerosis (MS). Participants will gain an understanding of the updated 2024 McDonald Criteria for MS diagnosis, emphasizing its application in clinical practice. The course highlights the importance of shared decision-making in selecting disease-modifying therapies and introduces emerging therapies currently in Phase 3 trials.